Results 71 to 80 of about 2,464,313 (253)

Depressive symptoms in cancer patients compared with people from the general population: the role of sociodemographic and medical factors [PDF]

, 2003
This study examined depressive symptoms in 475 patients with cancer and in a reference group of 255 individuals without cancer from the general population and the associations of those symptoms with sociodemographic and medical factors.
Schroevers, M.J., Schroevers, M.J.; id_orcid, Sanderman, R., Ranchor, A.V.   +3 more
core   +2 more sources

No Impact of Corticosteroid Use During the Acute Phase on Persistent Symptoms Post-COVID-19

International Journal of General Medicine, 2022
Adrien Chan Sui Ko,1,* Alexandre Candellier,2,* Marie Mercier,3 Cedric Joseph,1 Hortense Carette,3 Damien Basille,3 Sylvie Lion-Daolio,4 Stephanie Devaux,3 Jean-Luc Schmit,1 Jean-Philippe Lanoix,1 Claire Andrejak3 1Department of Infectious ...
Chan Sui Ko A, Candellier A, Mercier M, Joseph C, Carette H, Basille D, Lion-Daolio S, Devaux S, Schmit JL, Lanoix JP, Andrejak C   +10 more
doaj  

Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone, Freddy Chafota, Miguel E. Rentería, Randi J. Hagerman, Ellery Santos, Anna Atkinson, Nicholas G. Martin, Elsdon Storey, Danuta Z. Loesch   +8 more
wiley   +1 more source

Persistent Depressive Symptoms and Pain after Cardiac Surgery [PDF]

, 2014
ObjectiveOur objectives were to describe trajectories of depressive symptoms and pain at hospital discharge and 6 weeks later and to examine the relationship of persistent depressive symptoms to pain.MethodsBefore and 6 weeks after hospital discharge ...
Chen, Belinda, Bodán, Rebecca Cross, Irwin, Michael R, Doering, Lynn V, McGuire, Anthony   +4 more
core   +1 more source

[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich, Jonathan A. Gernert, Hanna Zimmermann, Lisa Tagnin, Marianthi Zeinaki, Laura Sanzo, Letizia Vogler, Elisabeth Kaufmann, Justina Dargvainiene, Frank Leypoldt, Gérard N. Bischof, Robert Perneczky, Boris‐Stephan Rauchmann, Simon Lindner, Günter U. Höglinger, Rudolf A. Werner, Martin Kerschensteiner, Tania Kümpfel, Matthias Brendel, Franziska S. Thaler   +19 more
wiley   +1 more source

Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial [PDF]

, 2010
Background: It has been demonstrated that cognitive behavioural therapy (CBT) has a moderate effect on symptom reduction and on general well being of patients suffering from psychosis.
Andreas Bechdolf, Wölwer, Wolfgang, Buchkremer Gerhard, Klingberg, Stefan, Tilo Kircher, Bernhard W Müller, Engel Corinna, Bechdolf Andreas, Klingberg Stefan, Wagner Michael, Engel, Corinna, Buchkremer, Gerhard, Corinna Engel, Wittorf, Andreas, Meisner Christoph, Christoph Meisner, Sartory, Gudrun, Wiedemann, Georg, Michael Wagner, Müller, Bernhard W., Sartory Gudrun, Wagner, Michael, Meisner, Christoph, Stefan Klingberg, Georg Wiedemann, Wiedemann Georg, Herrlich Jutta, Wittorf Andreas, Jutta Herrlich, König Hans-Helmut, Herrlich, Jutta, Andreas Wittorf, Wolfgang Wölwer, König, Hans-Helmut, Bechdolf, Andreas, Kircher Tilo, Wölwer Wolfgang, Kircher, Tilo, Hans-Helmut König, Gerhard Buchkremer, Gudrun Sartory, Müller Bernhard W   +41 more
core   +2 more sources

Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD‐Related Myelopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak, Marije M. C. Voermans, Hans Heijst, Charlotte E. Teunissen, Marc Engelen   +4 more
wiley   +1 more source

Depressive symptoms are associated with analgesic use in people with Alzheimer's disease: Kuopio ALSOVA study. [PDF]

, 2015
Neuropsychiatric symptoms of Alzheimer's disease (AD) such as depression may be associated with pain, which according to the literature may be inadequately recognized and managed in this population.
Eija Lönnroos, Soili Törmälehto, Janne Martikainen, Lönnroos, E, Saku Väätäinen, Hallikainen, I, ALSOVA Study Group, ., Ilona Hallikainen, Anne M Koivisto, Väätäinen, S, ALSOVA Study Group, Bell, JS, Lotta Salo, Salo, L, Martikainen, J, Törmälehto, S, Koivisto, AM, Gilmartin, JF, Julia Fiona-Maree Gilmartin, J Simon Bell   +19 more
core   +2 more sources

Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study

Frontiers in Pediatrics
BackgroundLong COVID in children remains a poorly understood condition with wide variability in clinical presentation, duration, and risk factors. The aim of this study was to assess the prevalence, spectrum, and duration of long COVID symptoms in ...
Vita Perestiuk, Tetyana Kosovska, Liubov Volianska, Oksana Boyarchuk   +3 more
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source